CGRWX
Price
$33.82
Change
-$0.08 (-0.24%)
Updated
Sep 8 closing price
Net Assets
772.15M
RMFCX
Price
$60.38
Change
-$0.07 (-0.12%)
Updated
Sep 8 closing price
Net Assets
109.46B
Interact to see
Advertisement

CGRWX vs RMFCX

Header iconCGRWX vs RMFCX Comparison
Open Charts CGRWX vs RMFCXBanner chart's image
Invesco Comstock Select A
Price$33.82
Change-$0.08 (-0.24%)
VolumeN/A
Net Assets772.15M
American Funds American Mutual R3
Price$60.38
Change-$0.07 (-0.12%)
VolumeN/A
Net Assets109.46B
CGRWX vs RMFCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CGRWX vs. RMFCX commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGRWX is a StrongBuy and RMFCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 109B vs. CGRWX (772M). CGRWX pays higher dividends than RMFCX: CGRWX (1.46) vs RMFCX (1.24). CGRWX was incepted earlier than RMFCX: CGRWX (40 years) vs RMFCX (23 years). CGRWX (0.93) and RMFCX (0.91) have similar cost to investors . CGRWX is a more actively managed with annual turnover of: 70.00 vs. RMFCX (31.00). RMFCX has a lower initial minimum investment than CGRWX: RMFCX (250) vs CGRWX (1000). RMFCX annual gain was more profitable for investors over the last year : 7.71 vs. CGRWX (-1.18). RMFCX (56.41) and CGRWX (54.74) have equivalent 5 years return.
CGRWXRMFCXCGRWX / RMFCX
Total Expense Ratio0.920.91101%
Annual Report Gross Expense Ratio0.930.91102%
Fund Existence40 years23 years-
Gain YTD9.45311.42183%
Front Load6%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets772M109B1%
Annual Yield % from dividends1.461.24118%
Returns for 1 year-1.187.71-15%
Returns for 3 years4.8332.1615%
Returns for 5 years54.7456.4197%
Returns for 10 years27.7991.1231%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATOS0.810.02
+2.42%
Atossa Therapeutics
IBO0.610.01
+1.16%
Impact BioMedical Inc.
BCAL17.200.10
+0.58%
California BanCorp
FFBC26.34-0.04
-0.15%
First Financial Bancorp
MAS75.80-0.27
-0.35%
Masco Corp